For the first time in its history, the DEA has approved THC for medical use. Unfortunately, it’s not the kind of THC you’re used to. This designer version of marijuana’s most psychoactive ingredient is made in the lab by pharmaceutical company Insys Therapeutics. It’s the only kind of THC that can be legally prescribed across the country, despite having the same chemical makeup as organic THC. The product is called Syndros and it comes in the form of an FDA-approved oral spray.
The DEA has classified Syndros as a Schedule II drug under the Controlled Substances Act, the same category as prescription drugs which allows it to be prescribed by doctors. Syndros will be used to treat pain in cancer patients. Organic THC found in the cannabis plant remains under Schedule I, the most restrictive category which suggests it has no medical benefit and a high potential for abuse. Other substances in that category include MDMA, heroin, and LSD. The decision has been controversial because of Insys’ history. The company allegedly bribed doctors and faked patients’ medical records to prescribe their Fentanyl-based oral spray called Subsys. Read the full story here.